Denifanstat showed positive Phase 3 results in acne, meeting all goals with strong safety, as Sagimet pushes ahead with a second FASN inhibitor trial.

Partner content Challenging your Box 3 tax: an issue that might pay dividends June 4, 2025 “Box 3” is not the third gift in a pile of Dutch presents – but it could be. Over the past years, the Dutch ...

Best characters Wuthering Waves 2.3 Phase 2 (Image via Kuro Games) Phase 2 of the Wuthering Waves 2.3 update officially kicked off on May 22, 2025, and it features several Resonators.

Kuro Games announced all the events and banners coming with Wuthering Waves 2.3 second phase. Since the ongoing update features the game's first anniversary, quite a few gameplay events are packed ...

Summary The Weeknd’s Hurry Up Tomorrow debuts with $3.3M USD at the box office Poor reviews and buzz hindered the $15M Lionsgate release. The film stars The Weeknd as an insomniac musician in an ...

Deadpool & Wolverine (2024) – $1.33 billion The combined worldwide box office gross for those six MCU Phase 5 movies is approximately $3.45 billion.

In summary, all of the new and returning 5-Star characters you can Warp on during 3.3 are: Hyacine (A Rainbow onto Twilight Banner - Phase 1): New 5-Star Wind character of The Remembrance path.

Retro vs HIT 3 Box Office Collection: HIT 3, starring Nani, outperformed Suriya's Retro at the box office in their first three days. HIT 3 earned ₹41.12 crore, while Retro made ₹34.72 crore.

The Union government cleared two corridors (44.6 km) of Phase 3 in August 2024, but the project faces delays as the Karnataka government pushes for the incorporation of double-decker flyovers ...

This paper proposes a large-signal black-box modeling technique of three-phase voltage source inverters. The resulting model is oriented to perform system-level analysis and is fully parameterized ...

Sikandar Box Office Collection As Sikandar crossed half of its first Tuesday, it stands at a Rs 61 lakh collection across all three languages and over 7,000 shows across India.

The STOP-HS clinical trial program includes two Phase 3 studies, STOP-HS1 (NCT05620823) and STOP-HS2 (NCT05620836), evaluating the efficacy and safety of povorcitinib (INCB54707) in adult patients ...